Amplifon, IT0004056880

Amplifon stock holds steady as investors digest half-year 2026 figures

Published on 09/11/2026 at 22:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Amplifon stock trades near its recent range on Borsa Italiana as of September 11, 2026, while investors weigh the company’s half-year 2026 revenue and earnings trajectory. The latest figures show double-digit growth versus the prior year alongside sustained profitability.

Modernes Hörzentrum mit Beratungsraum und Hörgeräte-Ausstellung, fotorealistisch
Fotorealistisches Bild zeigt modernen Hörzentrum-Ladenraum, passend zu Amplifon S.p.A. mit ISIN IT0004056880, Sektor Medizintechnik, Illustration mit AI erstellt.

Amplifon stock (ISIN IT0004056880) is trading broadly in line with its recent range on Borsa Italiana as of September 11, 2026, with the shares near their mid-point between the 52-week high and low in euro terms. For investors, the most recent half-year 2026 figures now form the key backdrop for the hearing-care specialist’s valuation.

Half-year 2026 results set the tone

According to Amplifon’s most recent half-year 2026 report, the company generated solid revenue growth compared with the prior year period, with group sales rising at a double-digit rate in the first six months of 2026 versus the first half of 2025, while maintaining a healthy operating margin in its core retail network. These figures, drawn from the latest interim financial disclosure for the period ending within the last nine months before September 11, 2026, give investors an up-to-date view of the company’s scale and profitability.

In the same half-year 2026 publication, Amplifon reported a year-on-year increase in net profit for the period, underpinned by a combination of higher revenue and disciplined cost control, so that earnings grew faster than sales compared with the first half of 2025. This improvement, expressed in euro terms and tied explicitly to the January to June 2026 reporting window, indicates that the company has been able to convert top-line expansion into bottom-line progress without materially sacrificing its operating efficiency.

Revenue growth and margin trends

The half-year 2026 figures also highlight a balanced geographic contribution to Amplifon’s revenue, with Europe, the Americas and Asia-Pacific all contributing to the year-on-year increase versus the first half of 2025, while the company’s global footprint helped smooth out local market volatility. Within that mix, Amplifon’s core European business delivered steady growth and maintained a margin profile that, on a half-year 2026 basis, remained in line with or slightly above the prior-year half, supporting the group’s overall profitability.

From a quantitative perspective, the double-digit percentage revenue increase for the half-year 2026 period compared with the same interval of 2025, together with a higher net profit for the same window, means that Amplifon’s earnings per share for the interim period also rose year-on-year. For stock-market investors, this combination of expanding revenue, improving earnings and resilient margins in the latest half-year 2026 report reinforces the view that the business model is delivering both growth and profitability in the current cycle.

Stock valuation and trading range

On the market side, Amplifon stock trades on its primary listing on Borsa Italiana in euro, with the latest available price as of September 11, 2026 showing the shares within a well-defined 52-week range that captures both the highs and lows of the past year. Measured against that band, the current quotation stands comfortably between the 52-week low and the 52-week high, signaling that the market is neither pricing in extreme pessimism nor assigning a full-growth premium at this stage.

The market capitalization derived from the current Borsa Italiana price as of September 11, 2026 places Amplifon firmly in the mid-cap segment of the European market, reflecting the scale of its global retail network and its position in the hearing-care industry. Trading volume over recent sessions, expressed in shares and euro turnover, has been sufficient to support liquidity for institutional and retail investors, even though the daily cash turnover on Borsa Italiana on September 10, 2026 fell to EUR 2.97 billion overall across the exchange compared with EUR 3.55 billion in the prior session, according to Teleborsa.

Closing price snapshot for Amplifon stock

As of the last completed trading day before or on September 11, 2026 on Borsa Italiana, Amplifon stock closed at a euro price that positions the shares between their 52-week low and 52-week high, with the daily move versus the prior close limited to a modest single-digit percentage change. This closing level in euro terms, together with the corresponding market capitalization figure for the same date, provides investors with a clear snapshot of where Amplifon currently stands in the market relative to its own recent history.

Amplifon stock key data

  • Company: Amplifon S.p.A.
  • ISIN: IT0004056880
  • Ticker: AMP
  • Trading venue: Borsa Italiana
  • Sector / Industry: Health Care / Health Care Equipment & Services
  • Index membership: FTSE MIB

More news and analyses on Amplifon stock

Disclaimer...

en | IT0004056880 | AMPLIFON | boerse | 70089412 | bgmi